Recent years have witnessed remarkable developments in the management of muscular dystrophy. Researchers are actively studying innovative strategies that hold promise for ameliorating the lives of individuals stricken by this degenerative illness. Drug development have emerged as particularly potent avenues for treating the underlying mechanisms of